8:00 - 19:00

Working hours MON. - FRI.

Fauci apologises for casting doubt over UK’s approval of Pfizer vaccine

LONDON (Reuters) - Anthony Fauci, the top U.S. infectious diseases expert, apologised on Thursday after casting doubt over the rigour of the British regulators who approved the Pfizer (NYSE:PFE) vaccine against COVID-19 and said he had faith in their work. "There really has been a misunderstanding, and for that I'm sorry, and I apologise for that," Fauci said in an...

Continue reading

Ulta Beauty Earnings beat, Revenue misses In Q3

Ulta Beauty (NASDAQ:ULTA) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Ulta Beauty announced earnings per share of $1.64 on revenue of $1.55B. Analysts polled by Investing.com anticipated EPS of $1.44 on revenue of $1.56B. Ulta Beauty shares are up 14.38% from the beginning of the year and are trading...

Continue reading

Ulta Beauty Lifts Q4 Guidance, but Falls on Mixed Results

By Yasin Ebrahim Ulta Beauty (NASDAQ:ULTA) lifted guidance for fourth-quarter comparable-store sales but reported a mixed third-quarter performance as earnings beat, but revenue fell of Wall Street expectations as stores temporarily closed due to COVID-19. Ulta Beauty (NASDAQ:ULTA) fell more than 6% following the report. "While it is difficult to predict future impacts of the pandemic on demand this holiday season, we have...

Continue reading

ECB denies report that it discussed potential plans by BBVA to grow further in Mexico and Turkey

FRANKFURT/MADRID (Reuters) - The European Central Bank on Thursday denied a newspaper report which had said that its supervision banking arm had discussed potential business plans by BBVA (MC:BBVA) to grow further in Mexico and Turkey. "Contrary to a Spanish front page news report today, ECB Banking Supervision has not yet discussed any future business plans with BBVA," an ECB spokesperson...

Continue reading

Splunk Spelunked After Disappointing Earnings; Analysts Drop Price Targets

By Christiana Sciaudone Investing.com --  Splunk (NASDAQ:SPLK) sank 23% after missing estimates and getting a range of price target decreases.  The software company reported a loss per share of 7 cents, well below the expected earnings per share of 9 cents with sales of $558 million missing the estimated $613 million. Splunk provided guidance for fiscal 2021 fourth quarter revenue of between $650...

Continue reading

Dow Above 30,000 Again, led by Boeing, Stimulus Progress

By Yasin Ebrahim The Dow rose Thursday above a key level led by a rise in Boeing on signs of demand returning for the beleaguered Max jets, while ongoing optimism for much-needed stimulus aid continued to underpinned investor sentiment. The Dow Jones Industrial Average rose 0.45%, or 172 points, rising above the 30,000 level intraday. The S&P 500 was up 0.15%, while the...

Continue reading

Airports reject vaccine requirement as travel debate intensifies

By Allison Lampert and Jamie Freed MONTREAL/SYDNEY (Reuters) - Aviation industry opposition to requiring mandatory COVID-19 vaccination for passengers has intensified as impending drug approvals trigger a debate over their role in air travel. Airports Council International, which represents airports worldwide, joined most airlines in calling for a choice between testing or vaccination,...

Continue reading

England announces new quarantine exemptions for “high-value” business travellers

LONDON (Reuters) - England announced new quarantine exemptions for "high-value" business travellers, performing arts professionals, journalists and certain others, meaning that if they meet certain conditions they will not have to self-isolate on arrival in the country. The exemptions will take effect from 4 a.m. (0400 GMT) on Dec. 5. As things stand, all passengers arriving in England from abroad are...

Continue reading
en_GBEnglish